Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bamboo Therapeutics

Bamboo Therapeutics
2014 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$645M LATEST DEAL AMOUNT
Description

Developer of gene therapies for the treatment of monogenic disorders. The company specializes in developing therapeutic reagents to diagnose diseases related to central nervous system and neuromuscular conditions.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Parent Company
Primary Office
  • 870 Martin Luther King Jr Boulevard
  • Chapel Hill, NC 27514
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bamboo Therapeutics’s full profile, request a free trial.

Bamboo Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Aug-2016 $645M 000.00 00000 Completed Startup
1. Early Stage VC 11-Feb-2016 000.00 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Bamboo Therapeutics Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenxbio Formerly VC-backed Rockville, MD 000 00000 00000000000 00000
0000000 000 Angel-Backed Bainbridge Island, WA 00000 0000000000 00000
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
0000000 0000000000 Formerly VC-backed Menlo Park, CA 00 00000 000000 - 000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Bamboo Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 00 0000 08-Jan-2016 000000000 00000 00 Buildings and Property 0000000 00000000 00.0
To view this company’s complete investment and acquisition history, request access »

Bamboo Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CureDuchenne Ventures Corporate Venture Capital Minority 000 0000 000000 0

Bamboo Therapeutics Executive Team (10)

Name Title Board
Seat
Contact
Info
Richard Samulski Ph.D Co-Founder, Chief Scientific Officer & Executive Chairman
Maritza McIntyre Ph.D Executive Vice President of Regulatory Affairs & Product Development
Sharon hesterlee Ph.D Executive Vice President, Patient Advocacy and Public Affairs
Richard Smith Ph.D Senior Vice President of Corporate Communications and External Affairs
Cynthia Rask Chief Medical Officer

2 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Bamboo Therapeutics Board Members (3)

Name Representing Role Since Contact
Info
Richard Samulski Ph.D Bamboo Therapeutics Co-Founder, Chief Scientific Officer & Executive Chairman 000 0000
Sheila Mikhail JD Self Co-Founder, Chief Executive Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »